|
HS Code |
495695 |
| Chemicalname | Methyl 5-Iodosalicylate |
| Casnumber | 603-40-1 |
| Molecularformula | C8H7IO3 |
| Molecularweight | 278.05 g/mol |
| Appearance | White to off-white solid |
| Meltingpoint | 112-114°C |
| Solubility | Slightly soluble in water, soluble in organic solvents |
| Density | 1.89 g/cm3 |
| Purity | Typically ≥98% |
| Smiles | COC(=O)C1=CC(=CC=C1I)O |
| Inchi | InChI=1S/C8H7IO3/c1-12-8(11)5-3-6(9)4-7(10)2-5/h2-4,10H,1H3 |
| Storagetemperature | Store at 2-8°C |
| Synonyms | 5-Iodo-2-hydroxybenzoic acid methyl ester |
As an accredited Methyl 5-Iodosalicylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Methyl 5-Iodosalicylate, 25g, is packaged in an amber glass bottle with a secure screw cap and tamper-evident seal. |
| Shipping | Methyl 5-Iodosalicylate is shipped in tightly sealed containers to prevent moisture or contamination, complying with standard hazardous material regulations. The package must be clearly labeled, cushioned to avoid breakage, and protected from extreme temperatures and direct sunlight. Transport is typically done via ground or air, following all relevant chemical shipping protocols. |
| Storage | Methyl 5-Iodosalicylate should be stored in a tightly sealed container, away from light, moisture, and incompatible materials such as strong oxidizers. Keep it in a cool, dry, and well-ventilated area, preferably in a chemical storage cabinet designated for organic compounds. Ensure appropriate labeling and limit access to authorized personnel to prevent contamination and hazardous exposure. |
Applications of Methyl 5-Iodosalicylate in Industrial ManufacturingMethyl 5-iodosalicylate, produced by our integrated chemical facilities, serves as a specialized building block in high-value downstream sectors where regulatory, compositional, and process requirements demand consistent purity and traceability. Our production supports advanced manufacturers in life sciences, active pharmaceutical ingredient synthesis, crop protection intermediates, specialty dyes, and material science formulation domains. Below, we outline specific application scenarios matched to actual and compliant production ecosystems. 1. Pharmaceutical Intermediate for Iodinated Active CompoundsMajor pharmaceutical plants employ this compound as a targeted intermediate in the synthesis routes of selected iodinated drug substances, particularly where regulated aryl iodide moieties are necessary for molecular frameworks. During API manufacture, strict traceability and impurity control monitoring apply, with this intermediate introduced at designated coupling or substitution steps, aligned with master batch protocols and documentation audits under global GMP regimes. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Building Block for Herbicide and Fungicide IntermediatesFormulators in crop protection chemistry utilize methyl 5-iodosalicylate in controlled syntheses of key intermediates essential for modern herbicide and fungicide active ingredient production, emphasizing batch reproducibility, impurity profiling, and environmental registration compliance. The product enters production lines at substitution or cyclization phases preceding formulation, particularly where selective iodo-functional groups enhance biological activity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Synthesis of Functional Organic Dyes and PigmentsDownstream producers in the specialty colorants sector incorporate methyl 5-iodosalicylate into multi-step syntheses of aryl iodide–containing dyes where chromophore modification and halogen incorporation dictate light stability, solubility, and absorption spectra. Production lines leverage the chemical’s reactivity to introduce controlled iodo groups, optimizing yield and pigment performance for industrial textile and imaging applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Material Science: Precursors for Crosslinked Polymers and Specialty ResinsSpecialty material and polymer manufacturers employ methyl 5-iodosalicylate as a functionalized aryl source to introduce halogen content within crosslinkable resin systems, enhancing UV-curability, thermal resistance, and surface reactivity. The compound is incorporated at prepolymer synthesis or modification phases, where raw material tracking and batch equivalence are mandatory for quality assurance and final property reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Methyl 5-Iodosalicylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Our team has been synthesizing Methyl 5-Iodosalicylate with an eye on both consistency and flexibility. The compound, featuring the chemical formula C8H7IO3, takes its structure from a methyl ester derivative of 5-iodosalicylic acid. Chemists often shorthand this product simply as “5-Iodo-methyl salicylate,” a name that pops up again and again in benchwork logs, requests, and project notes. This isn’t an ordinary building block. Halogenation at the 5 position transforms its reactivity and versatility, compared to unsubstituted methyl salicylate or other iodoaromatic esters.
We manufacture this product through direct iodination, strictly controlling reaction temperature and time to avoid polysubstitution or unwanted side reactions. Each batch passes through GC and HPLC for purity assessment, with spectral data archived for reference. The majority of demand finds us supplying as a fine, white to off-white crystalline powder, though some custom solutions require slurry or solution forms, especially where downstream reaction speed matters.
Standard specifications target over 98% purity, with ≤0.5% moisture content and low levels of unreacted precursors. Melting point testing and NMR analysis round out our primary quality controls. We continuously monitor for heavy metal contaminants, especially iodine-associated residues, to keep within globally accepted safe ranges. Our experience points to the importance of not only high purity but also batch-to-batch reproducibility—slight differences in residual solvents or byproducts have derailed projects, especially those targeting sensitive downstream syntheses.
Common packaging sizes range from small laboratory vials up to multi-kilogram drums for pilot or commercial production. Many customers, especially those in pharmaceutical research, seek custom particle size control since heterogeneous reactions sometimes favor larger or finer grains. Based on routine feedback, our most popular model holds a 500g net content, sealed under nitrogen to minimize oxidative degradation. Conventional methyl salicylate does not present the same storage or handling concerns, so those switching to the iodinated version often find unanticipated shelf stability issues—a nuance that only becomes clear after losing a carefully stored sample to excess humidity.
Our own technical staff has observed the majority of production routes using Methyl 5-Iodosalicylate as a key intermediate for Suzuki-Miyaura couplings. The robust aryl-iodine bond supports efficient cross-coupling under mild conditions. We have repeatedly seen demand spike when newer medicinal chemistry leads pursue biaryl structures, heterocycle functionalization, or radiolabeling. Many routes toward iodine-125 labeled tracers in nuclear medicine deploy derivatives of this compound, since the methyl ester protects from unwanted decarboxylation or acidic hydrolysis.
Colleagues in agrochemical research often prefer the 5-iodo substitution pattern due to favorable electronic and steric profiles, opening up options for ring transformations otherwise limited on chlorinated or brominated analogs. Compared to methyl 3-iodosalicylate or methyl 4-iodosalicylate, the 5-iodo isomer frequently delivers higher yields in cyclization and amide formation reactions. Our project notes sometimes trace entirely new pathways for flavor and fragrance molecules, leveraging the unique balance of reactivity and stability carried by the compound.
We have also provided technical assistance for teams using this compound in post-synthetic modification—especially ortho-lithiation and carbometalation work, where the iodine atom brings increased regioselectivity. Some academic collaborators prefer it as a starting point for C–H activation studies. The lab notes returned from several European partners stress the improvement they saw merely by switching from bromine to iodine—reaction times dropped, and less forcing conditions yielded cleaner products. These empirical differences do not always register in theory, but day-to-day synthetic outcomes reveal them clearly.
Experience shows that switching from 5-iodosalicylic acid to the methyl ester often solves solubility and handling headaches. The methyl group imparts greater hydrophobicity, which matters tremendously in certain organic solvents or during crystallization. Compared to the acid, the ester fits into organic syntheses without risk of unwanted acid-base interactions. On multiple occasions, pharmaceutical projects have failed screening due to trace acids in starting materials—substituting the methyl ester avoids these pitfalls.
Among halo-substituted salicylates, the iodine atom brings distinctly different reactivity. Chlorinated or brominated salicylates may suit electrophilic aromatic substitution, but the iodo version unlocks much more efficient oxidative addition and coupling reactions. Our QC team has tried direct head-to-head synthesis runs using 5-chlorosalicylic acid methyl ester, and each time, the iodo analog demonstrates faster conversions and fewer side reactions during palladium-catalyzed steps. There is always a cost implication—the iodinated compound carries higher raw material expense and stricter regulatory oversight due to its iodine content. Still, operations that value efficiency and purity rarely settle for the cheaper, less reactive halogens when the synthetic gain is so apparent.
Hydroxyl and ester groups on the benzene ring further differentiate Methyl 5-Iodosalicylate from unfunctionalized methyl benzoates. The ortho relationship between the iodine and carboxylate offers unique reactivity, enabling transformations that demand precise regiochemistry. Not every process needs this specificity, but certain natural product syntheses simply do not work without it. One example sticks with us—a client in fine chemicals failed for months to construct a critical fused ring system. Switching to our product allowed them to convert a stalled intermediate in days. Out in the literature, these kinds of anecdotes run deep, reinforcing decisions made in our labs every day.
Consistency is everything for teams doing scale-up or transfer to production. An intermediate may pass analytical tests for a few grams, yet when processed at multi-kilogram scale, trace impurities or inconsistent particle size lead to batch failures. Years of back-and-forth with contract partners taught us that simply publishing a “typical” purity spec misses the point. Actual usability comes from verifying not only the assay but also the residual solvent matrix, polymorph stability, and even the effect of packaging material on the product during transport.
We have fielded urgent calls about off-color product arriving at destination, only to track the root cause to packaging not suited to prolonged transit in tropical climates. Not one technical data sheet ever specifies sunlight resistance or permeability ratings, yet this is how real, usable inventory gets lost. Our facility conducts in-house stress trials on outgoing batches, logging temperature and humidity excursions. This approach keeps returns down and customer timelines on track, though it comes at higher operational costs.
On occasion, we review project failures due to minute variation in iodine content from batch to batch. Excess free iodine or incomplete reaction transfer can poison downstream catalysts or create stubborn byproducts. We routinely check for less-than-obvious contaminants such as polyiodinated impurities, which may pass unnoticed in basic UV or melting point tests. Investing in full-spectrum NMR and X-ray fluorescence detection paid off in faster problem resolution and more productive feedback loops with both research and process engineers.
Iodinated aromatics fall under stricter oversight because of their potential for bioaccumulation and environmental toxicity. Even minor spills or waste streams must receive careful handling. Our waste management protocols include secondary containment, off-site incineration, and routine audits by accredited external partners. We track our outputs for trace iodine and associated organics to maintain compliance with both national restrictions and global conventions.
Some research partners requested documentation related not just to analytical purity but also to how byproducts are disposed and how packaging materials align with circular economy goals. As manufacturers, facing these questions underscores how chemical stewardship moves beyond mere numbers on a certificate. Costs go up, but the consequence of mismanaged halogenated waste impacts both the bottom line and the company’s standing in stakeholder networks.
Shipping regulations also shift the ground. The International Air Transport Association updates restrictions on certain iodinated chemicals, and we have reworked labeling and containment several times after regulatory advisories. Direct experience taught us not to rely solely on freight forwarders for compliance; engaging with both authorities and corporate customs specialists keeps shipments moving rather than parked indefinitely in inspection zones.
Producing halogenated aromatics introduces process safety challenges. Iodination reactions expose workers to both corrosive agents and volatile byproducts. Our plant design separates iodination from post-reaction isolation and purification. We employ local exhaust, upgraded PPE, and continuous atmospheric sensors—measures driven by real incidents rather than by-the-book projections. Team members have contributed countless hours troubleshooting equipment fouling and minimizing operator exposure in high-throughput settings.
Scale presents constant friction. The same procedure used for a 10g test run breaks down at 10kg. Mechanical agitation must be tuned to prevent heterogeneity in the reaction vessel, while heat transfer limits create hot spots that foster impurities. Our shift supervisors traded standard glassware for jacketed reactors early on, later coupling with automated sampling to log reaction progress and pre-empt runaway side reactions. Retrofitting older lines to handle the higher density and corrosivity of iodinated intermediates demanded investment, but paid off with higher yields and fewer shutdowns.
Waste handling looms large. No generic quench and neutralize approach suffices—the presence of unreacted iodine and organic byproducts poses both cost and environmental risk. Over time, we moved toward solvent recovery and iodine recycling systems, cutting hazardous waste output by more than half. This shift proved essential in maintaining both regulatory standing and good neighbor relations within our industrial park.
As manufacturers, our perspective remains grounded by what works in the lab and out on the plant floor. Many product innovations started not with a push from marketing but with troubleshooting real-world synthetic roadblocks. For example, our team responded to a client’s difficulty in cleanly isolating intermediates by developing a high-purity, low-moisture version of Methyl 5-Iodosalicylate tailored to avoid hydrolysis-sensitive downstream chemistry. Feedback led us to recalibrate drying protocols and alter storage recommendations—small details, yet crucial for projects chasing tight timelines or large regulatory filings.
We also see value in long-term technical partnership. Contract manufacturers up against impossible deadlines have leveraged our expertise in process adaptation, from batch record sharing to support during tech transfer. We help researchers avoid stumbling into classic pitfalls—undocumented side reactions, improper solvent selection, or even just improper handling on the bench. This open dialog leads to faster troubleshooting and more consistent results in route design and optimization.
Few chemicals operate in a vacuum. Methyl 5-Iodosalicylate’s role often gets defined by the demands of continuous innovation. The explosion of biopharmaceutical research, the uptake of targeted radiolabeling, and the growth of specialty polymer design all fuel shifts in demand pattern and required competencies. We maintain readiness to adjust specification profiles, deliver non-standard batch sizes, and certify to a higher level of trace impurity documentation.
Many requests come tied to strict project confidentiality, and our management platform supports secure transfer of analytical data, Certificates of Analysis, and process know-how. This is not “off the shelf” chemistry—it’s collaborative science with real people solving actual problems. Our lab and plant teams document not only what worked, but what failed, so that partners do not have to repeat avoidable mistakes. For complex, multi-step syntheses, we trace each raw material lot, ensuring full traceability, especially vital in pharma or regulated specialties.
Where standard intermediates fail, specialty halogenated aromatics fill the gap. We’ve seen Methyl 5-Iodosalicylate drive project pivots, open up new reaction space, and shorten timelines not only for those steeped in synthetic organic chemistry but also for multidisciplinary teams exploring new molecular territories. While commoditized processes might lean toward the cheapest or most readily available ingredient, our real customer base values consistency, transparency, and a track record of safely handling challenging chemistries.
The current research climate demands not only materials but also expertise. As regulatory trends evolve and new competitor pathways emerge, those able to supply high-quality, fully documented specialty intermediates such as Methyl 5-Iodosalicylate hold an edge. Our direct feedback system with development chemists informs our continuous improvement program. By sharing information, adapting our processes, and maintaining rigorous quality standards, we support broader scientific progress while keeping feet squarely on the factory floor.
Methyl 5-Iodosalicylate stands out not just due to its molecular structure, but by the technical history written into each batch we deliver. Authentic experience with the quirks, challenges, and opportunities of halogenated intermediates can make the difference between a stalled synthesis and a project breakthrough. By focusing on reliability, open communication, and ongoing technical adaptation, we supply more than a product—we help build the foundation for both incremental and transformative progress across chemical, pharma, and allied sectors.